Selected Reading
- Austin MA et al: Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 82:495, 1990
- Chait A et al: Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 94:350, 1993
- Gianturco SH, Bradley WA: Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: Cellular aspects. Clin Cardiol 22(Suppl II):7, 1999
- Hamsten A et al: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557, 1985
- Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:231, 1996
- Miller M et al: Normal triglyceride levels and coronary artery disease events: The Baltimore Coronary Observational Long-Term Study (COLTS). J Am Coll Cardiol 31:1252, 1998
- Otvos J: Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy. Clin Cardiol 22(Suppl II):21, 1999
- Segal A et al: Hypertriglyceridaemia and vascular risk: Report of a meeting of physicians and scientists, University College of London Medical School. Lancet 342:781, 1993